Firefly neuroscience reports third quarter 2024 results and provides stockholder update

Company successfully listed on nasdaq under the symbol “aiff” partnered with multiple neuroscience pharmaceutical companies, including bright minds bioscience, and neurologists to advance company's dual go-to-market strategy toronto, nov. 14, 2024 (globe newswire) -- firefly neuroscience, inc. (“firefly,” “we,” or the “company”) (nasdaq: aiff), an artificial intelligence (“ai”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended september 30, 2024, and provided a stockholder update. firefly is dedicated to improving outcomes for people suffering with brain health illnesses by bringing objective measurement of brain activity to the front lines of healthcare.
AIFF Ratings Summary
AIFF Quant Ranking